Flow Diversion Aneurysm Treatment Market Size, Share, Trends, Growth Outlook

Flow Diversion Aneurysm Treatment Market is estimated to increase at a growth rate of 8.1% CAGR over the forecast period from 2024 to 2030.

The global Flow Diversion Aneurysm Treatment Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (FDS, Intrasaccular flow disruption devices), By End-User (Hospitals, Specialty clinics).

An Introduction to Flow Diversion Aneurysm Treatment Market in 2024

The Flow Diversion Aneurysm Treatment Market involves innovative neurovascular devices and technologies used in the endovascular treatment of intracranial aneurysms. Flow diversion devices, such as stents and implants, redirect blood flow away from the aneurysm sac, promoting thrombosis and reducing the risk of rupture. This market offers minimally invasive solutions for treating complex and wide-necked aneurysms, improving patient outcomes, and advancing the field of neurointerventional surgery.

Flow Diversion Aneurysm Treatment Market Competitive Landscape

The global Flow Diversion Aneurysm Treatment Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Flow Diversion Aneurysm Treatment Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Flow Diversion Aneurysm Treatment Industry include- BALT Group, Cardinal Health Inc, Endologix LLC, Evasc Medical Systems Corp, Imperative Care Inc, InNeuroCo, InspireMD Inc, Johnson and Johnson, Lepu Medical Technology Beijing Co. Ltd, Medtronic Plc, Merlin MD Pte. Ltd, MicroPort Scientific Corp, Oxford Endovascular Ltd, Penumbra Inc, Rapid Medical Ltd, Siemens AG, Stryker Corp, Terumo Corp, WallBy Medical LLC.

Flow Diversion Aneurysm Treatment Market Trend: Increasing Preference for Minimally Invasive Procedures

A significant trend in the flow diversion aneurysm treatment market is the rising preference for minimally invasive procedures over traditional surgical interventions for the management of intracranial aneurysms. Flow diversion involves the placement of a stent-like device across the neck of the aneurysm to divert blood flow away from the aneurysm sac, promoting thrombosis and subsequent occlusion. This approach offers advantages such as reduced procedural risks, shorter hospital stays, and faster recovery times for patients, leading to growing adoption by neurosurgeons and interventional radiologists. This trend reflects the increasing demand for innovative treatment options that balance efficacy with safety and patient comfort, driving market growth and innovation in flow diversion technologies.

Flow Diversion Aneurysm Treatment Market Driver: High Incidence of Intracranial Aneurysms

A key driver in the flow diversion aneurysm treatment market is the high incidence of intracranial aneurysms, which pose a significant risk of rupture and life-threatening hemorrhage if left untreated. Intracranial aneurysms affect millions of individuals worldwide, with a considerable proportion being asymptomatic and incidentally discovered on imaging studies. Given the potentially catastrophic consequences of aneurysm rupture, there's a strong clinical imperative to identify and treat high-risk aneurysms to prevent morbidity and mortality. This demographic trend, coupled with advancements in endovascular technologies and techniques, drives market demand for flow diversion devices as a minimally invasive and effective treatment option for intracranial aneurysms, supporting market growth and adoption.

Flow Diversion Aneurysm Treatment Market Opportunity: Expansion into Adjacent Indications

One Market Opportunity in the flow diversion aneurysm treatment market lies in the expansion of indications beyond intracranial aneurysms to include other neurovascular pathologies such as intracranial stenosis, arteriovenous malformations (AVMs), and dural arteriovenous fistulas (dAVFs). Flow diversion technology has demonstrated efficacy in redirecting blood flow and promoting vascular remodeling in various vascular lesions beyond aneurysms, offering opportunities to address unmet clinical needs in neurointerventional procedures. By exploring new applications and investing in clinical research and development, medical device companies can leverage their expertise in flow diversion technology to expand market reach, improve patient outcomes, and capture additional market share in neurovascular interventions.

Flow Diversion Aneurysm Treatment Market Share Analysis: FDS (Flow Diverter Stents) is the fastest growing market segment over the forecast period to 2030

Among flow diversion aneurysm treatment options, Flow Diverter Stents (FDS) are experiencing the fastest growth. FDS are innovative devices designed to treat intracranial aneurysms by diverting blood flow away from the aneurysm sac, promoting thrombosis, and ultimately leading to the exclusion of the aneurysm from the circulation. These stents are constructed from a mesh-like structure of metallic alloys such as cobalt-chromium or nickel-titanium, featuring high porosity to allow for sufficient blood flow redirection while maintaining vessel patency. In contrast, intrasaccular flow disruption devices work within the aneurysm sac to promote thrombosis, but they are generally considered less effective in treating large or wide-necked aneurysms compared to FDS. The increasing adoption of FDS is driven by their superior efficacy in treating complex aneurysm morphology, including wide-necked and fusiform aneurysms, as well as their minimally invasive nature, which reduces the risk of complications associated with traditional open surgical procedures. Hospitals and specialty clinics are the primary end-users of FDS, where neurointerventionalists perform these procedures under fluoroscopic guidance. With advancements in device technology, including improved stent design, delivery systems, and bioactive coatings, the market for FDS in flow diversion aneurysm treatment is expected to continue its rapid growth, offering safer and more effective treatment options for patients with intracranial aneurysms.

Flow Diversion Aneurysm Treatment Market Segmentation

By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Flow Diversion Aneurysm Treatment Companies

BALT Group
Cardinal Health Inc
Endologix LLC
Evasc Medical Systems Corp
Imperative Care Inc
InNeuroCo
InspireMD Inc
Johnson and Johnson
Lepu Medical Technology Beijing Co. Ltd
Medtronic Plc
Merlin MD Pte. Ltd
MicroPort Scientific Corp
Oxford Endovascular Ltd
Penumbra Inc
Rapid Medical Ltd
Siemens AG
Stryker Corp
Terumo Corp
WallBy Medical LLC
* List not Exhaustive

Reasons to Buy the Flow Diversion Aneurysm Treatment Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Flow Diversion Aneurysm Treatment Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Flow Diversion Aneurysm Treatment Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Flow Diversion Aneurysm Treatment Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Flow Diversion Aneurysm Treatment Market Size Outlook, $ Million, 2021 to 2030
3.2 Flow Diversion Aneurysm Treatment Market Outlook by Type, $ Million, 2021 to 2030
3.3 Flow Diversion Aneurysm Treatment Market Outlook by Product, $ Million, 2021 to 2030
3.4 Flow Diversion Aneurysm Treatment Market Outlook by Application, $ Million, 2021 to 2030
3.5 Flow Diversion Aneurysm Treatment Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Flow Diversion Aneurysm Treatment Industry
4.2 Key Market Trends in Flow Diversion Aneurysm Treatment Industry
4.3 Potential Opportunities in Flow Diversion Aneurysm Treatment Industry
4.4 Key Challenges in Flow Diversion Aneurysm Treatment Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Flow Diversion Aneurysm Treatment Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Flow Diversion Aneurysm Treatment Market Outlook by Segments
7.1 Flow Diversion Aneurysm Treatment Market Outlook by Segments, $ Million, 2021- 2030
By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
8 North America Flow Diversion Aneurysm Treatment Market Analysis and Outlook To 2030
8.1 Introduction to North America Flow Diversion Aneurysm Treatment Markets in 2024
8.2 North America Flow Diversion Aneurysm Treatment Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Flow Diversion Aneurysm Treatment Market size Outlook by Segments, 2021-2030
By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
9 Europe Flow Diversion Aneurysm Treatment Market Analysis and Outlook To 2030
9.1 Introduction to Europe Flow Diversion Aneurysm Treatment Markets in 2024
9.2 Europe Flow Diversion Aneurysm Treatment Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Flow Diversion Aneurysm Treatment Market Size Outlook by Segments, 2021-2030
By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
10 Asia Pacific Flow Diversion Aneurysm Treatment Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Flow Diversion Aneurysm Treatment Markets in 2024
10.2 Asia Pacific Flow Diversion Aneurysm Treatment Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Flow Diversion Aneurysm Treatment Market size Outlook by Segments, 2021-2030
By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
11 South America Flow Diversion Aneurysm Treatment Market Analysis and Outlook To 2030
11.1 Introduction to South America Flow Diversion Aneurysm Treatment Markets in 2024
11.2 South America Flow Diversion Aneurysm Treatment Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Flow Diversion Aneurysm Treatment Market size Outlook by Segments, 2021-2030
By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
12 Middle East and Africa Flow Diversion Aneurysm Treatment Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Flow Diversion Aneurysm Treatment Markets in 2024
12.2 Middle East and Africa Flow Diversion Aneurysm Treatment Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Flow Diversion Aneurysm Treatment Market size Outlook by Segments, 2021-2030
By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
BALT Group
Cardinal Health Inc
Endologix LLC
Evasc Medical Systems Corp
Imperative Care Inc
InNeuroCo
InspireMD Inc
Johnson and Johnson
Lepu Medical Technology Beijing Co. Ltd
Medtronic Plc
Merlin MD Pte. Ltd
MicroPort Scientific Corp
Oxford Endovascular Ltd
Penumbra Inc
Rapid Medical Ltd
Siemens AG
Stryker Corp
Terumo Corp
WallBy Medical LLC
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
FDS
Intrasaccular flow disruption devices
By End-User
Hospitals
Specialty clinics